OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GEMA56

Gem Aromatics Ltd

Specialty ChemicalsVerified

Gem Aromatics Ltd has a debt-to-equity ratio of 0.79, indicating a moderate reliance on debt financing, and a current ratio of 1.91, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's operating cash flow is negative at -249.16 million INR, and its free cash flow is also negative at -443.63 million INR, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 18.8%, and its return on assets (ROA) is 9.99%. These figures are strong and suggest that the company is effectively utilizing its equity and assets to generate returns. The gross profit margin is 25.4%, and the operating margin is 17.05%, both of which are key metrics for evaluating performance in the specialty chemicals industry. The company's revenue is concentrated across four product categories: mint and mint derivatives, clove and clove derivatives, phenol, and other synthetic and natural ingredients. It operates three manufacturing facilities in India and serves a diverse range of industries, including oral care, cosmetics, and pharmaceuticals. However, the company's revenue concentration by segment is not disclosed, and there is no information on geographic revenue distribution. The company's growth trajectory is not explicitly outlined in the provided data, but its capital expenditure of -1.05 billion INR indicates significant investment in its operations. The outlook for the current fiscal year and the next fiscal year is not provided, but the company's recent financial performance suggests a need for careful monitoring of its cash flow and liquidity position. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity issue. The dilution potential is low, and no adjustments have been applied to the valuation metrics. Recent events and filings are not detailed in the provided data, but the company's financial snapshot and risk assessment suggest that it is operating in a competitive and capital-intensive industry. The company's recent capital expenditures and negative cash flows indicate a focus on expansion and operational improvements.

30-day price · GEMA+8.04 (+5.2%)
Low$138.06High$182.60Close$162.56As of12 May, 00:00 UTC
Profile
CompanyGem Aromatics Ltd
TickerGEMA.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Gem Aromatics Ltd is a manufacturer of specialty ingredients, including essential oils, aroma chemicals, and derivatives, primarily derived from mint and clove oil, serving industries such as oral care, cosmetics, and pharmaceuticals.

Classification. Gem Aromatics Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Gem Aromatics Ltd has a debt-to-equity ratio of 0.79, indicating a moderate reliance on debt financing, and a current ratio of 1.91, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's operating cash flow is negative at -249.16 million INR, and its free cash flow is also negative at -443.63 million INR, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 18.8%, and its return on assets (ROA) is 9.99%. These figures are strong and suggest that the company is effectively utilizing its equity and assets to generate returns. The gross profit margin is 25.4%, and the operating margin is 17.05%, both of which are key metrics for evaluating performance in the specialty chemicals industry. The company's revenue is concentrated across four product categories: mint and mint derivatives, clove and clove derivatives, phenol, and other synthetic and natural ingredients. It operates three manufacturing facilities in India and serves a diverse range of industries, including oral care, cosmetics, and pharmaceuticals. However, the company's revenue concentration by segment is not disclosed, and there is no information on geographic revenue distribution. The company's growth trajectory is not explicitly outlined in the provided data, but its capital expenditure of -1.05 billion INR indicates significant investment in its operations. The outlook for the current fiscal year and the next fiscal year is not provided, but the company's recent financial performance suggests a need for careful monitoring of its cash flow and liquidity position. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity issue. The dilution potential is low, and no adjustments have been applied to the valuation metrics. Recent events and filings are not detailed in the provided data, but the company's financial snapshot and risk assessment suggest that it is operating in a competitive and capital-intensive industry. The company's recent capital expenditures and negative cash flows indicate a focus on expansion and operational improvements.
Key takeaways
  • Gem Aromatics Ltd has a strong ROE of 18.8% and ROA of 9.99%, indicating effective use of equity and assets.
  • The company's debt-to-equity ratio of 0.79 suggests a moderate reliance on debt financing.
  • Negative operating and free cash flows highlight potential liquidity constraints.
  • The company's capital expenditure of -1.05 billion INR indicates significant investment in operations.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$5.04B
Gross profit$1.28B
Operating income$859.2M
Net income$533.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$249.2M
CapEx-$1.05B
Free cash flow-$443.6M
Total assets$5.35B
Total liabilities$2.51B
Total equity$2.84B
Cash & equivalents$11.3M
Long-term debt$2.25B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$5.04B$859.2M$533.8M-$443.6M
FY-1$4.52B$759.7M$501.0M$172.2M
FY-2$4.25B$705.3M$446.7M$350.5M
FY-3$3.14B$472.1M$311.9M$213.3M
FY-4$3.06B$407.8M$231.9M$210.7M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$5.35B$2.84B$11.3M
FY-1$3.69B$2.31B$158.8M
FY-2$2.96B$1.80B$105.8M
FY-3$2.40B$1.38B$65.0M
FY-4$1.86B$1.10B$81.7M
PeriodOCFCapExFCFSBC
FY0-$249.2M-$1.05B-$443.6M
FY-1$276.3M-$391.4M$172.2M
FY-2$153.2M-$143.8M$350.5M
FY-3-$52.0M-$141.9M$213.3M
FY-4-$3.9M-$54.0M$210.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$789.0M$51.8M-$49.9M
FQ-1$895.2M$76.1M-$25.8M
FQ-2$876.3M$200.0M$79.8M
FQ-3$2.02B$502.7M$276.1M
FQ-4$968.4M$199.7M$74.6M
FQ-5$1.12B$198.8M$97.4M
FQ-6$926.7M$178.1M$85.9M
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1$6.58B$4.55B$336.2M
FQ-2
FQ-3$5.35B$2.84B$11.3M
FQ-4
FQ-5$4.17B$2.49B$56.5M
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1$212.1M-$669.4M
FQ-2
FQ-3-$249.2M-$1.05B
FQ-4
FQ-5$174.6M-$400.9M
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.84B
Net cash-$2.24B
Current ratio1.9
Debt/Equity0.8
ROA10.0%
ROE18.8%
Cash conversion-47.0%
CapEx/Revenue-20.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricGEMAActivity
Op margin17.0%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin10.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin25.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-20.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity79.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:19 UTC#c8afbf79
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 10:21 UTCJob: ec16c296